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INTRODUCTION 
 Ante partum fetal surveillance is the corner stone of preventive obstetric 
management aimed at reducing maternal and perinatal mortality and morbidity. 
Ante partum detection of fetus at risk of death or compromise in utero remains 
the major challenge in modern obstetrics. Specific and accurate methods for 
detection of fetus at risk can result in early appropriate intervention and hence 
reduce fetal loss. Antenatal test of fetal well being depends indirectly on 
changes in fetal physiology, an aspect of fetus, which until recently, has been 
relatively inaccessible to study by the paucity of techniques to measure the 
placental function - the critical organ through which the transfer of nutrients 
occur. New technologies have now become available in the clinical assessment 
of placental function. Doppler measurement of the pulsatile blood velocity in 
umbilical artery gives direct information on feto-placental circulation and 
hence identifies placental circulatory failure. 
Diagnostic ultrasound is the main stay in the evaluation and 
management of obstetric patients. Fetal growth and development rely on 
normal uteroplacental and fetoplacental circulation to supply oxygen and 
nutrients from the maternal circulation. Doppler sonography offers a unique 
tool for the noninvasive evaluation of physiological hemodynamic 
fetoplacental blood flow information. There are specific abnormalities in 
Doppler parameters in asymmetric intrauterine growth retardation. 
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Fetal Growth Restriction (FGR), otherwise known as Intrauterine 
Growth Restriction is defined as a pathologic decrease in the rate of fetal 
growth. Here the fetus does not achieve its inherent growth potential, thereby 
increasing perinatal morbidity and mortality. Small for gestational age (SGA) 
is conceptually not the same entity as FGR. It is defined as fetus which has 
failed to achieve specific and arbitrary anthropometric measurements or weight 
threshold by a specific gestational age, whereas in FGR, the infant has not 
achieved its genetic growth potential in utero (Rajan. R. 2001). 
All FGR fetuses don't suffer from in utero compromise in terms of 
hypoxia or acidemia. Fetal growth restriction only means that the fetus has not 
grown appropriately for the corresponding gestational age, and does not 
necessarily mean it is a situation of uteroplacental respiratory insufficiency 
causing fetal hypoxia or acidemia. But many IUGR fetuses could sooner or 
later become hypoxemic, hypoxic and acidotic as a progressive event of the 
pathophysiology. 
 Diagnosis of IUGR is based on B-mode ultrasound. Estimation of fetal 
weight in utero using multiple ultrasound parameters remains the mainstay in 
screening for FGR. Use of various fetal morphometric ratios and/or 
measurements of other fetal parameters may provide additional useful 
information. Serial evaluation to assess interval growth may be necessary to 
clarify the diagnosis. 
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 Doppler velocimetry has poor sensitivity in detecting IUGR, whereas it 
is helpful in assessing the hemodyanmic state. Doppler indices change if the 
fetus is compromised due to hypoxemia. 
 Doppler flow velocimetry, particularly of the middle cerebral and 
umbilical arteries is an earlier predictor of hypoxemia, when compared to BPP 
or NST. Ductus venosus flow study is an accurate predictor for acidemia. 
 The relationship between the size of fetal abdominal circumference and 
fetal head is used to characterize the pattern of FGR as being either symmetric 
or asymmetric. Symmetric IUGR refers to a growth pattern in which the 
growth of both the fetal abdomen and head are decreased proportionally. 
Asymmetric IUGR refers to the growth-retarded fetus in which a 
disproportionate decrease in the size of fetal abdomen with respect to the fetal 
head is seen. 
 Symmetric IUGR may result from an early insult such as genetic or 
infective pathology that impairs fetal cellular hyperplasia and therefore causes 
a proportionate decrease in size of all fetal organs. By contrast, asymmetric 
IUGR may be caused by a later insult that impairs cellular hypertrophy, causes 
a disproportionate decrease in the size of fetal abdomen in relation to that of the 
fetal head. Progressive uteroplacental insufficiency may be associated with this 
asymmetric growth pattern. 
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 Nearly 70% of patients with IUGR may be classified as having an 
asymmetrical growth pattern. These cases may be at greater risk for perinatal 
hypoxia and neonatal hypoglycemia. However, their long-term prognosis with 
appropriate management is good. 
 Symmetric IUGR results from an early insult and is characterized by a 
long period of subnormal growth. These infants usually do not have perinatal 
hypoxia, but they are at risk of long-term neurodevelopmental dysfunction, 
resulting from a deficit in the total number of brain cells. 
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AIMS AND OBJECTIVES 
1. To detect any abnormalities in fetoplacental unit and fetal circulation in 
IUGR. 
2. To identify the hypoxemic fetus & timing delivery so as to precede 
acidemia. 
3. To correlate the occurrence of adverse perinatal outcome with degree of 
abnormality in doppler indices. 
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REVIEW OF LITERATURE 
           To avoid undue alarm in patients, to whom the term "Retardation" 
implies abnormal mental function, the term "Fetal growth restriction" is now 
preferred. About 3-10% of infants are growth restricted (Divon and HSU, 
1992)1. 
 In 1961, Warkany and co-workers2 reported normal values for infant 
weight, lengths and head circumferences which served to define fetal growth 
restriction. In 1963, Gruenwald3 reported that approximately one third of low 
birth weight infants were mature and that their small size could be explained by 
"chronic placental insufficiency". 
 In 1963, Lubchenco and coworkers5 from Denver published detailed 
comparisons of gestational ages to birth weights in an effort to derive norms for 
expected fetal size and therefore growth at a given gestational week. Battagalia 
and Lubchenco (1967)6 classified small for gestational age infants as those 
whose weights were below the 10th percentile for their gestational age. The 
neonatal mortality rate of a small for gestational age infant born at 38 weeks 
was 1 percent compared with 0.2% in those with appropriate birth weights. 
Seeds and Peng (1998)7 concluded that the threshold for impaired growth based 
upon the risk of fetal death should be set even higher at the 15th birth weight 
percentile. 
 Manning and Hohler (1991)8 and Gardosi (1992)9 concluded that 25-
60% of infants conventionally diagnosed to be small for gestational age were in 
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fact appropriately grown when determinants of birth weight such as maternal 
ethnic group, parity & weight are considered. 
 A definition based upon birth weight below the fifth percentile was also 
proposed by Seeds (1984)10. Usher and McLean (1969)11 proposed that fetal 
growth standards should be based on mean values with normal limits defined 
by + 2 standard deviations because this definition would limit small for 
gestational age infants to 3% of births instead of 10% with use of the 10th 
percentile. From a clinical standpoint this definition appears to be most 
meaningful. This is because most poor outcomes are in those infants with birth 
weights below the third percentile. 
 In a study of 122,754 pregnancies delivered at Parkland Hospital, 
Mclntire and Colleagues (1999)12 found that mortality and morbidity were 
significantly increased among infants born at term only when their birth 
weights were at or below the third percentile for their gestational age. 
Relationship between birth weight percentile and perinatal mortality & 
morbidity is observed on 1560 SGA fetuses. A progressive increase in both 
mortality and morbidity is observed as birth weight percentile falls. (Manning 
1995)13. 
 Owen and Colleagues in 199714 and Owen and Khan in 199815 reported 
that reduction in the rate of velocity of fetal growth detected by serial 
ultrasonic fetal anthropometry is related to caesarean delivery for fetal distress 
and significant fetal growth restriction. 
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 Fetal growth restriction is associated with substantial perinatal mortality 
and morbidity. Incidence of fetal demise, birth asphyxia, meconium aspiration, 
neonatal hypoglycemia and hypothermia are all increased, as is the prevalence 
of abnormal neurological development (Paz 199516, Piper 199617). Postnatal 
growth and development of growth - restricted fetuses depends on the cause of 
restriction, nutrition in infancy and social environment (Kliegman 199718). 
Infants with growth restriction due to congenital, viral infection, chromosomal 
or maternal constitutional factors remain small throughout life. Those infants 
with in utero growth restriction due to placental insufficiency will often have 
catch up growth after birth and approach their inherited growth potential when 
provided with an optimal environment. 
 Campbell and Thorns (1977)19 described the use of the sonographic head 
to abdomen circumference ratio (HC/AC) to differentiate fetuses into subtypes 
- "Symmetrical" meaning proportionately small and "Asymmetrical" meaning 
those with disproportionately lagging abdominal growth. 70% of the fetuses 
with a HC/AC ratio above the 95th percentile were termed asymmetrical. Even 
though similar gene realization exists, those with aneuploidy typically had 
disproportionately large head size (Nicolaides 1991)20. 
 Similarly most preterm infants with growth restriction due to 
preeclampsia and associated uteroplacental insufficiency demonstrate a 
symmetrical pattern of growth impairment rather than the hypothesized 
asymmetrical pattern (Salafia 1995)21. 
  Dash and Colleagues (2000)22 analyzed HC/AC ratio. Only 20% of 
growth restricted fetuses were at increased risk for intrapartum and neonatal 
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complications.  Symmetrically growth restricted fetuses with birth weight less 
than 10th percentile were not at increased risk of adverse outcomes. 
 Early establishment of gestational age, attention to maternal weight gain, 
careful measurement of uterine fundal growth throughout pregnancy will serve 
to identify many cases of abnormal fetal growth in women without risk factors.  
Identification of risk factors, including a previously growth restricted fetus 
should raise the possibility of recurrence during the current pregnancy in 
women with significant risk factors, for whom serial sonography is considered.  
Definitive diagnosis, however, usually cannot be made until delivery. 
 Identification of the inappropriately growing fetus remains a challenge; 
such identification is not always possible even in the nursery.  Carefully 
performed serial fundal height measurements throughout gestation are a simple, 
safe, inexpensive and reasonably accurate screening method to detect many 
small for gestational age fetuses (Gardosi and Francis 1999)23  But its principal 
drawback is imprecision.  Jenson and Larsen (1991)24 and Walraven (1995)25 
found that symphysis to fundal measurements helped to correctly identify only 
40% of such infants.  Thus, small for age infants are either over-looked or over-
diagnosed.  Despite this, carefully measured fundal height is still considered as 
a simple screening method. 
 The method to measure fundal height by using a measuring tape was 
first reported by Jimenez and colleagues (1983)26.  Between 18 and 30 weeks 
the uterine fundal height in centimeters coincides with the weeks of gestation.  
If the measurement is more or less than 2-3cm from the expected height, 
inappropriate fetal growth may be suspected. 
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           Routine screening incorporates an ultrasound examination at 16-20 
weeks to establish gestational age and rule out visible anomalies, and then 
follow-up imaging at 32-34 weeks to evaluate fetal growth .Combining head, 
abdomen and femur dimensions should in theory enhance the accuracy of 
predictions of fetal size. But any potential improvement is apparently lost by 
the cumulative error inherent in measurement of each individual fetal 
dimension.  Thus most experts have accepted abdominal circumference 
measurements as the most reliable index of fetal size (Manning et al13 1995; 
Smith 199727, Snijders & Nicolaides 199428).  In these studies, estimated fetal 
weight calculated with abdominal circumference measurements was almost 
always within 10% of the actual birth weight. 
 The use of ultrasound for detection of fetal growth restriction does not 
preclude missed diagnoses.  Dash and Colleagues (2000)22 studied 8400 live 
births at Parkland hospital of those women who had ante partum ultrasound 
within 4 weeks of delivery. Although 70% of growth restricted fetuses were 
detected, 30% were missed. 
Risk Factors of IUGR 
Constitutionally small mothers 
 
 Small women typically have smaller babies.  Data from a longitudinal 
study of all births during one week in 1958 in England, Wales and Scotland 
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indicate that there are intergenerational effects on birth weight that are 
transmitted through the maternal line (Emanuel 1992)29. Klebanoff (1997)30 
reported that reduced intrauterine growth of the mother is a risk factor for 
reduced intrauterine growth of her children.  Brooks and co-authors (1995)31 
analyzed 62 births where the relative influence of the donor versus the recipient 
on birth weight, after ovum donation, was examined.  They concluded that the 
environment provided by the mother was more important that her genetic 
contribution to birth weight. 
Poor maternal weight gain and nutrition 
 In the women of average or low weight, lack of weight gain throughout 
pregnancy may be associated with fetal growth restriction (Simpson1975)32. 
Lack of weight gain in the second trimester strongly correlates with decreased 
birth weight (Abrams and Selvin 1995). 
Social Deprivation 
 Williams (2001)34 wrote "the social condition of the mother and the 
comforts by which she is surrounded also exert a marked influence upon child's 
weight, heavier children being more common in the upper walks of life". 
Fetal Infections 
 Viral, bacterial, protozoan and spirochetal infections are implicated in 
upto 5% of cases of fetal growth restriction (Klein and Remington 1995)35 -
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Rubella, Cytomegalovirus virus, Hepatitis A, Hepatitis B, Listeriosis, 
Tuberculosis, Syphilis, Toxoplasmosis and congenital Malaria. 
Congenital malformations 
 With major structural anomalies, 22% had accompanying growth 
restriction (Khoury 1988)36.  More severe the malformation, the more likely the 
fetus is to be small for gestational age. 
Chromosomal abnormalities 
 Placental insufficiency, primary abnormal cellular growth and 
differentiation may contribute to the significant degree of fetal growth 
restriction associated with karyotype abnormalities. 
 Prominent postnatal growth failure occurs in trisomy 21, whereas fetal 
growth restriction is generally mild (Thelander, Pryor 1966)37.  Trisomy 18 is 
associated with severe fetal growth restriction. 
 Trisomy 16 is the most common trisomy in spontaneous abortions and is 
lethal to the fetus in non-mosaic state (Lindor 1993)38  Patches of trisomy 16 in 
the placenta called "confined placental mosaicism" leads to placental 
insufficiency  & may account for many cases of previously unexplained fetal 
growth restriction (Kalousek 1993)39. Here chromosome abnormality is 
confined to placenta.  Inherited syndromes such as osteogenesis imperfecta and 
various chondrodystrophies are associated with fetal growth restriction. 
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Chemical teratogens 
 Anticonvulsants such as phenytoin and trimethadione may produce 
specific and characteristic syndromes that include fetal growth restriction 
(Hanson 1976)40. Cigarette smoking causes growth restriction as well as 
preterm delivery in a direct relationship with the number of cigarettes smoked 
(Cliver 1995)41. Narcotics decrease maternal food intake and fetal cell number.  
Alcohol acts in a linear dose related fashion. 
Vascular disease 
 Chronic vascular disease, especially when complicated by superimposed 
pre-eclampsia, commonly causes growth restriction.  Pre-eclampsia, by itself 
may cause fetal growth failure, when the onset is before 37 weeks (Xiong 
1999)42. 
 Renal disease may be accompanied by restricted fetal growth 
(Stettlerand Cunningham 1992)43. 
Chronic hypoxia 
 Fetuses of women who reside at high altitude usually weigh less than 
those born to women who live at a lower altitude.  Fetuses of women with 
cyanotic congenital heart diseases are frequently severely growth restricted 
(Patton 1990)44. 
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Maternal anemia 
 Sickle cell anemia or other inherited anemias associated with serious 
maternal disease cause fetal growth restriction. 
 Deficient total maternal blood volume early in pregnancy is linked to 
fetal growth restriction (Duvekot 1995)45. 
Placental and cord abnormalities 
 Chronic partial placental separation, extensive infarction, 
chorioangioma, circumvallate placenta, placenta previa, marginal insertion of 
the cord and velamentous insertions are all accompanied by growth restricted 
fetuses.  Many cases of IUGR occur in pregnancies with apparently normal 
fetuses with grossly normal placentas.  Growth failure in these cases is 
presumed to be due to uteroplacental insufficiency. Women with otherwise 
unexplained FGR demonstrated a four-fold reduction in uteroplacental blood 
flow compared with normally grown fetuses (Lunell and Nylund 1992)46.  
Similar reductions were also seen in growth restricted fetuses with congenital 
malformations suggesting that maternal blood flow might in part be regulated 
by the fetus (Howard 198747).  Uteroplacental blood flow is also reduced in 
women with pre-eclampsia compared with normotensive women.   
Multiple fetuses 
Twin pregnancy is more likely to be complicated by diminished growth 
of one or both fetuses compared with normal singletons. Growth restriction has 
been reported in 10-50% of twins (Hill 1994)48. 
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Antiphospholipid antibody syndrome 
 Two classes of antibodies, associated with fetal growth restriction, are 
anticardiolipin antibodies and lupus anticoagulant (Lockwood and Rand 
1994)49.  Pathophysiological mechanism in the fetus appears to be caused by 
maternal platelet aggregation and placental thrombosis. 
DOPPLER VELOCIMETRY 
Basic principles 
 Doppler shift is a physical principle that states that when a source of 
light or sound wave is moving relative to an observer, observer detects a shift 
in the wave frequency.  Thus, when sound waves strike a moving target, the 
frequency of sound waves reflected back is shifted proportionate to the velocity 
and direction of the moving target.  As the magnitude and direction of the 
frequency shift depend on the relative motion of the moving target, their 
velocity and direction can be determined (Williams, 2001)34. 
Doppler principle is used to determine the volume and rate of blood 
flow through maternal and fetal vessels.  Here, the sound source is ultrasound 
transducer & moving targets are the red blood cells flowing through the 
circulation. When the distance between the source of sound and the reflector 
changes, there is a change in the frequency of the reflected echo-Doppler shift -
which is converted by the machine to 3 different kinds of output, namely; 
¾ Audio output on a loudspeaker-characteristic for each vessel-we can 
identify each vessel easily 
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¾ Spectral waveform-is also unique to each vessel. The pattern of the 
waveform depends largely on the distal vascular impedance and the 
compliance of the vessel.  
¾ Colour doppler- used to code the blood flow in a portion of the vessel. 
Flow toward the transducer is shown as red and away from the 
transducer as blue. 
Duplex ultrasound: B- mode, color flow and spectral waveform together are 
called triplex mode. 
Doppler is generally used in two ways to estimate circulatory 
hemodynamics: 
1. Direct measurement of volume of blood flow. 
2. Indirect estimation of flow velocity using wave form analysis. 
Blood flow measurement 
Errors in direct measurement of the volume of blood flow have led to 
the development of several indirect indices of flow, which are independent of 
the angle of insonation and do not require measurement of the diameter of the 
vessel. 
Colour Doppler is switched on to locate the vessel, then the pulsed 
Doppler sample volume is placed on the vessel and optimal spectral waveforms 
are obtained.  
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Specific measurements like peak systolic velocity (PSV) and the end 
diastolic velocity (EDV) are made from this optimal spectral waveform, and 
the various ratios are computed. If the peak systolic velocity is called "S" and 
the end diastolic velocity is called "D" the various ratios calculated are 
 (1) S/D ratio 
 (2) Resistance  Index (RI) = S-D/S 
 (3) Pulsatility Index (PI) = S-D / Mean 
 
Mean velocity is the average of all the velocities that are present during 
one cardiaccycle and is computed by the machine. Of these, the PI, according 
to Gosling and King (1975)50 would seem to be best suited for practical 
purposes, as it increase linearly with increasing flow impedance. 
            All ultrasound equipment will have measurement facility and in most 
equipment, an automatic trace of the waveform is made as the waveform is 
being generated in real time.  
Uterine and arcuate arteries 
 
Uterine artery is a branch of the internal iliac artery,arising close to the 
bifurcation. Uterine blood flow increase from 50ml/mt shortly after conception 
to 500 to 750 ml/mt by  term..Doppler waveforms of the uterine artery undergo 
gradual changes in their charecterestics with advancing gestation. 
 
¾ A sharp systolic peak and forward flow in diastole 
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¾ Upto 16 wks of gestation an early diastolic notch can be 
noticed(represents the presence of elastic coat in the spiral arteries) 
 
¾ Beyond this period, the notch disappears (18-23wks)(due to 
trophoblastic invasion of spiral arterioles). 
 
¾ Diastolic velocity increases and thus the indices decrease as term 
approaches(SieroszewskiP 2005)51 
 
¾ Failure of the pattern to appear or the presence of a notch in the 
waveform at end systole after mid trimester  has been reported with fetal 
growth restriction(Schulman 1986)52         
 
¾ Women with abnormal uterine artery Doppler indices and persistence of 
notch are at high risk of obstetric comlications (Papageorghiou, 
Nicolaides 2002)53 
 
¾ Women with normal uterine artery doppler have low risk of developing 
obstetric complications related to placental dysfunction. 
 
¾ Following a positive test the risk of developing preeclampsia is 
increased by 6 times and the risk of  developing IUGR is increased by 3 
times (Papageorghiou 2002)53 
 
¾ However a meta analysis of observational studies on uterine artery 
Doppler in predicting IUGR&preeclampsia,showed that the likelihood 
ratios did not alter the pre test probabilities of IUGR and preeclampsia 
 
 
20
in a great way-Hence the utility of doppler as a screening test for pre-
eclampsia and IUGR is guarded(Chien 2000)54 
 
UMBILICAL ARTERY 
Anatomy 
The umbilical arteries arise from the internal iliac arteries of the fetus 
and course along the umbilical cord to reach the placenta. Intraplacentally, they 
branch into primary, secondary and tertiary stem villous vessels, which form 
the placental vascular bed. As pregnancy advances, increase in tertiary stem 
villi leads to steady decrease in vascular bed resistance. 
Normal umbilical artery waveforms 
¾ In early weeks of gestation the umbilical artery reveals absent diastolic 
flow. 
¾ Beyond 15 weeks of gestation, diastolic flow is consistently seen. 
¾ As pregnancy advances, there is an increase in diastolic flow and the RI 
is low. 
Abnormal umbilical artery waveforms 
¾ Seen when 70% of the tertiary villi are affected (IUGR is seen even 
when 40% are affected).This is the reason why umbilical artery doppler 
cannot be used as a screening test for IUGR. 
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¾ 3 types of abnormalities are seen(indication of increasing  resistance 
which correlates with fetal hypoxia)                                                                                    
a) Low diastolic flow (high resistance) 
b) Absent diastolic flow 
c) Reversed flow in diastole 
             A meta-analysis of all randomized studies of doppler ultrasound of 
umbilical artery in IUGR by Alfirevic and Neilson in 199555 concluded that all 
women with suspicion of IUGR should have access to Doppler of the umbilical 
artery. 
       Elevated PI, RI or S/D ratios in umbilical and uterine arteries have been 
correlated to morphological changes in placental vascular bed (Olofsson et al 
1993)56. 
       Gudmundsson and Marshal in 199157 showed that ARED in umbilical 
artery Doppler, 96% of these fetuses showed hypoxia or asphyxia at delivery. 
These results indicate that umbilical artery Doppler has the capacity to find 
those SGA fetuses that are truly at risk of developing asphyxia and therefore 
need surveillance. Additional information may be found in the other vascular 
beds. 
Cerebral blood flow 
¾ Doppler evaluation of blood flow through cerebral vessels allows 
detection of altered cerebral circulation before  hypoxemia significant 
enough to change the fetal heart rate has occurred 
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¾ Middle cerebral artery is the most accessible vessel and has been 
reported to demonstrate reduction in the pulsatility index at the onset of 
hypoxemia (Wladimiroft 1991)58. 
¾ Chandran and colleagues (1993)59 compared middle cerebral artery 
pulsatility indices with fetal heart rate analysis in 27 growth restricted 
fetuses, and found that Doppler was a more sensitive predictor of 
hypoxemia at birth than fetal heart rate testing but had lower specificity.             
¾ Unlike the uterine and umbilical vascular beds which constantly change 
with advancing gestational age, the MCA vascular bed resistance is 
almost constant throughout pregnancy (the RI is 0.75-0.85). 
¾ This is due to the fact that the intracerebral flow is controlled by an auto 
regulatory mechanism which responds to fetal oxygen saturation. 
¾ Reduction in the oxygen saturation (hypoxemia) causes dilatation of the 
intracerebral vessels, leading to increased flow or decreased cerebral 
resistance (Vyas, Nicolaides et al 1990)60. 
¾ Cephalisation of flow is associated with redistribution of cardiac output 
in favour of the left ventricle preferentially perfusing the brain and 
myocardium with oxygenated blood (Al-ghazali et al 1987)61. This 
occurs during hypoxia and is reflected in MCA as increased diastolic 
flow with reduced RI. 
¾ With increasing hypoxia, the fetus can become acidemic which results in 
cerebral edema. This causes increased cerebral resistance and diastolic 
flow in the MCA may be reduced or even absent. This indicates poor 
prognosis.    
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¾ Demonstration of cephalisation enhances the positive predictive value of 
an elevated umbilical artery Doppler index for hypoxemia. 
¾ This brain sparing effect has been evaluated in animal studies and 
confirmed in human studies(Malcus et Al62 1991,Mari and Deter 1992)63  
¾ Further it pre-dates the appearance of late decelerations on the CTG strip 
of IUGR fetus by an average of two weeks (Arduini et al 1992)64. 
Cerebroplacental ratio 
¾ A ratio of the resistances in the umbilical artery and the MCA can be 
compared for better interpretation of fetal hypoxia. 
¾ In normal fetuses, the placental vascular resistance decreases as 
pregnancy advances, whereas the MCA resistance is constant. 
¾ The RI of MCA / RI of Umb. A is more than 1. 
¾ In cerebral redistribution, the MCA RI decreases and the umbilical 
artery increases, leading to cerebroplacental ratio of less than 1, 
indicating fetal hypoxia. 
¾ Clinical reports suggest that ratios between cerebral and umbilical 
arteries have the best predictive values for adverse outcome in growth 
restricted fetuses. 
¾ Gramellini et al 199265 found the diagnostic accuracy for the cerebro 
placental ratio to be 90% for predicting adverse outcome in IUGR, 
compared to 83% and 79% for umbilical artery and MCA alone 
respectively in the same study. 
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Ductus venosus 
 In venous Doppler, the first and most important conduit in fetal 
circulation is the ductus venosus. 
¾ It is a narrow vessel which arises from the transverse portion of the left 
portal vein and is connected to the IVC. 
¾ It is funnel shaped and has a muscular coat. 
¾ 45% of the blood from the umbilical vein enters the right atrium via the 
IVC through the ductus venosus, bypassing the liver. 
¾ The ductus venosus waveform has a typical M pattern 
¾ The audio signals of the ductus venosus have a typical rhythmic musical 
quality which is very characteristic. 
¾ Doppler of the ductus is only indicated if the umbilical artery and MCA 
are abnormal. 
¾ Cardiac deterioration is associated with acidemia.  Here venous studies 
are informative (Baschat et al 2000)66.   
¾ Venous indices reflect ventricular function and to a certain extent 
cardiac overload. Prolonged hypoxemia leads to hypoxemic 
cardiomyopathy, ventricular dysfunction, and a fall in cardiac output.  
As cardiac output declines, central venous pressure rises causing 
increased reversed flow during atrial systole.  As the severity intensifies, 
direction of blood flow in the ductus venous reverses during atrial 
contraction causing pulsatile umbilical venous flow.  Its development is 
associated with decreased fetoplacental perfusion and intra uterine fetal 
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death (Gudmunsson et al 199376).  It is in these late stages, reversal of 
diastolic flow in umbilical artery is observed. 
¾ An abnormal ductus waveform is recognized when there is a dip in the 
A wave, i.e. when the forward flow during atrial systole is less. This 
causes an increase in PI. 
¾ Reversal of A wave indicates cardiac decompensation and acidemia. 
¾ Growth restricted fetuses with abnormal venous flow have worse 
perinatal outcome compared to those where flow abnormality is 
confined to umbilical or MCA (Baschat et al 2000)66. 
¾ In a majority of severely growth restricted fetuses, sequential 
deterioration of arterial and venous flows precedes biophysical score 
deterioration. 
¾ Thus, the typical progression begins with increased resistance in the 
umbilical artery followed by decreased resistance in the middle cerebral 
artery and is completed with the development of abnormal venous 
waveforms as cardiac function deteriorates. 
¾ Adding serial doppler of umbilical artery MCA and DV to IUGR 
surveillance will enhance the performance of biophysical score in 
detecting fetal compromise and optimizing the time of intervention 
(Baschat et al 2001)67. 
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MATERIALS AND METHODS 
 This study was conducted jointly at the Institute of Obstetrics and 
Gynecology and Barnard Institute of Radiology, Chennai both coming under 
the Madras Medical College, Chennai. Two hundred documented IUGR cases 
confirmed by clinical evaluation and serial ultrasound biometry were selected 
for the study and it was done on singleton pregnant women with well-
documented period of gestation beyond 34 weeks. Known congenital 
anomalies were excluded from the study. 
           The machine used for Doppler was an Aloka 3500 color Doppler 
machine with a 3.5 to 5 MHz curvilinear probe. 
 Name, Age, Unit, Registration number and Address of the patients were 
noted.  Detailed obstetric history including the history of pregnancy induced 
hypertension; gestational diabetes and chronic hypertension were obtained.  
History of previous pregnancies including birth weight of previous babies, 
perinatal deaths, and mode of delivery were elicited.  Details of present 
pregnancy were asked, including the date of last menstrual period, details of 
scan in the first trimester and clinical examination noting, if available, were 
scrutinized. 
 A note was made of the maternal weight, blood pressure and obstetric 
examination findings of fundal height and various laboratory investigation 
results.  Those with uterine fundal height less than 3cms from the expected 
height were clinically diagnosed as IUGR and ultra sound examination was 
done with special emphasis on morphometric measurements. Abdominal 
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circumference less than 5th percentile and estimated foetal weight less than 
10th percentile for that gestational age were selected for study.  In cases with 
risk factors, serial sonography was done to identify fetal growth restriction.  
Initial dating scan followed by second ultra-sound examination was done at 
around 34 to 36 weeks. 
 Patients with irregular cycles, unknown dates, those with restricted 
growth from the 1st trimester onwards by ultrasound and pelvic examination 
were excluded from the study group as were those with history of viral 
exanthematous fever, intake of drugs like antiepileptics, antipsychotics & 
anticoagulants. 
 All these cases were kept under surveillance till confinement.  A careful 
search for causes of IUGR like Smoking, Alcoholism and Hypertension were 
made.  Anemia, if present, was corrected and PIH, if detected, was managed 
appropriately. The cases were monitored by Fetal Kick Count, 
Cardiotocography, Serial measurements of fetometry AFI and Doppler studies.  
Doppler studies were done on Umbilical artery, Middle Cerebral Artery and 
Ductus venosus with a real time color Doppler ultra sound machine.  Umbilical 
cord was located in the pool of amniotic fluid and values were taken at mid 
cord or placental insertion.  Middle cerebral artery was localized in transverse 
section of fetal skull, at the level of thalamus in the Sylvian fissure. The ductus 
venosus was sampled in the abdominal circumference section, where it joins 
the umbilical vein to IVC. The Doppler transducer was placed on the 
abdominal wall over the uterus and carefully manipulated till Doppler signals 
appropriate for those particular vessels were identified. 
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 The signals were recorded for a minimum of 5 to 8 cycles with blood 
flow velocity waveforms of equal shape and amplitude and of satisfactory 
quality were obtained.  The image was frozen and measurements taken.  
Doppler was considered as abnormal when there was absent or reverse diastolic 
flow in umbilical artery or PI values were above the 95th percentile for that 
gestational age.  Cerebro placental ratio less than one was also taken as 
abnormal. 
 Those cases where fetal assessment was normal were monitored 
fortnightly till delivery.  Those with absent and reverse flow were taken up for 
termination of pregnancy. In those cases with low diastolic flow in umbilical 
artery, where fetal maturity adequate for survival was present, the pregnancy 
was terminated.  In cases where fetal maturity was not reached monitoring was 
done with NST and BPP daily or twice weekly depending upon the severity of 
abnormality and associated complications.  Pregnancy was terminated when 
there were abnormal readings from CTG or a low score on the bio-physical 
profile. In those cases where differential shunting of blood flow to fetal brain 
was present, termination was done even before NST or BPP were found to be 
abnormal.  Mode of delivery was planned depending on the weight and 
gestational age and amount of liquor present.  Outcome of pregnancy was 
recorded in detail including intrauterine demise, neonatal death, birth weight, 
Apgar score, development of neonatal complications and presence of 
congenital anomalies, placental weight and pathology.  These details were 
entered in a proforma and the data was statistically analyzed and evaluated. 
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 Procedure of Obstetric ultrasound examination and Doppler evaluation 
performed are given below. 
FETOMETRY 
Biparietal Diameter 
 Measurement was performed from the outer edge of skull on the 
proximal surface, to the inner edge of skull on the distal surface in a section 
that included the midline echo with the cavum septum pellucidum in the 
anterior third and the thalami on either side.  During the study, care was taken 
to apply minimal pressure to the maternal abdomen with the transducer as the 
fetal head compression is associated with alterations of intra-cranial arterial 
flow velocity waveforms (Vyas et al 198987). 
Head Circumference 
 It was measured at the same level as the BPD using the method of 
expanding ellipse. 
Femur Length 
 A section showing both ends of the femur clearly was obtained and 
measurement of diaphysis was performed. 
Abdominal circumference 
 A cross sectional view of the fetal abdomen showing the intrahepatic 
portion of umbilical vein in the anterior third of the abdominal circumference 
was used for measurement of abdominal circumference by the expanding 
ellipse method. 
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DOPPLER EVALUATION 
Umbilical Artery 
 A loop of umbilical cord close to the placenta was located.  The segment 
of umbilical cord was elongated so that the two umbilical arteries and one 
umbilical vein could be distinguished.  Angle of insonation was adjusted to less 
than 60 degrees.  An optimum Doppler signal was obtained and the pulsatility 
index was measured. 
 
 PI 
28 Weeks 1.2 
40 Weeks 1.1 
 
Foetal Middle Cerebral Artery 
 Section of foetal head used for BPD measurement was obtained and then 
the transducer was angled caudally till the middle cerebral artery was seen 
coursing along the sphenoid wings.  Sample volume size and angle of 
insonation were adjusted after placing the cursor in the artery and appropriate 
signals obtained.  The pulsatility index was measured. 
 PI 
28 Weeks 2.1 
40 Weeks 1.5 
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 In FGR, the expected abnormal findings would be an increased diastolic 
flow due to the cephalisation of blood flow and brain sparing effect.  This 
would reflect as a decrease in PI values. 
Foetal ductus venosus 
A transverse section of the fetal abdomen was obtained with the 
transducer angled slightly cephalad, color flow switched on and the aliasing 
signal in the ductus venosus identified where it connects the umbilical vein to 
the IVC. 
The sample volume and the angle of insonation were set and the 
waveform obtained. The  PI was then  measured. 
 PI 
28 Weeks 1.1 
40 Weeks 0.8 
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OBSERVATIONS 
 The study was conducted on 200 third trimester women with 
ultrasonologically confirmed IUGR cases and the following observations were 
made. 
 Among the 200 cases that were confirmed to be IUGR by B-Mode 
Ultrasound, 179 cases showed abnormalities in the Doppler wave forms. 21 
cases revealed normal Doppler wave forms. 
 
TABLE NO.1 
 
Total No of IUGR Cases 200 % 
Normal Doppler 21 10.5 
Abnormal Doppler 179 89.5 
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GRADING OF DOPPLER ABNORMALITIES 
According to the increasing severity of altered Doppler indices in the 
200 IUGR cases, we categorized the cases into six from grade 0 (normal 
Doppler) to grade 5. 
Table showing details of Doppler abnormalities. 
TABLE NO. 2 
GRADES No % 
0 Normal doppler 21 10.5 
1 Increased UA PI alone 38 19 
2 CPR  reversal 93 46.5 
3 Absent/reversed EDF in UA with   decreased 
MCA PI 
19 9.5 
4 Absent/reversed EDF  in UA with increased 
MCA PI 
23 11.5 
5 Ductus venosus alteration 6 3 
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 Out of the 179 cases, 48 cases showed absent/reversed diastolic flow in 
umbilical artery, out of which 19 had compensated MCA flow while 23 had 
gone in for decompensated MCA flow (hypoxic and decompensated fetus),    
38 cases showed only low diastolic flow in umbilical artery, 93 cases showed 
low diastolic flow in umbilical artery and increased diastolic flow in middle 
cerebral artery (hypoxic and compensated fetus). 6 cases showed increased PI 
in the ductus (acidotic fetus). 
 Representative normal and abnormal tracings from the study are shown 
on plates attached. 
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AGE DISTRIBUTION 
The age distribution of the patients in our study is shown in the 
following table. 
TABLE NO.3 
Age Group No of patients Percentage (%) 
18-22 61 30.5 
23-27 93 46.5 
28-31 40 20 
32-36 5 2.5 
> 36 1 0.5 
 
Most of the patients were in the age group of 23-27 yrs. There was only 
1 patient more than 36 years of age. 
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GRAVIDITY 
This table shows the birth order of the patients in our study group. 
 
TABLE NO.4 
Gravidity No. of Patients Percentage (%) 
PRIMI 108 54 
SECOND 51 21.5 
THIRD 34 17 
FOURTH AND 
MORE 
7 3.5 
 
Majority of our patients were primigravidae (54%).Only 7 patients were 
of the birth order 4 or more. 
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GESTATIONAL AGE 
 The distribution of gestational age at which Doppler analysis was done 
in the study group is shown in the table below. 
TABLE NO. 5 
GESTATIONAL 
AGE(WEEKS) 
NUMBER OF PATIENTS                           
GRADE 
34-36 0 0 0 0 0 5 5  [2 %] 
36-37 2 5 17 11 13 1 49  [24%] 
37-38 1 3 26 6 6 0 42  [21%] 
38-39 7 16 25 2 3 0 53  [26 %] 
39-40 10 12 24 0 0 0 46  [23%] 
> 40 1 2 2 0 0 0 5   [2%] 
 
Most of our patients with mild Doppler abnormalities were adequately 
monitored till term or even beyond. Patients with higher grades of Doppler 
abnormalities were induced earlier based on their biophysical profile, non 
stress test and liquor status for best fetal outcome. 
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RISK FACTORS 
 This table shows the distribution of risk factors in the study group. 
67(33.5%) of them had pregnancy induced hypertension as the risk factor. In 
5cases (2.5%) gestational diabetes was the identified risk factor.6 cases(3%) 
had heart disease  complicating pregnancy. 48 cases (24 %) had one of the 
other risk factors like breech, postdates, bronchial asthma, anaemia, 
hypothyroidism or chronic hepatitis. 102 patients(54%) had no risk factors. 
TABLE NO. 6 
Risk Factor No. of Patients Percentage (%) 
Preeclampsia 67 33.5 
Gest.  Diabetes 5 2.5 
Heart disease 6 3 
Epilepsy 5 2.5 
Others 48 24 
None 102 51 
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Table showing mode of delivery 
TABLE NO.7 
Doppler grade Mode of 
delivery 
0 1 2 3 4 5 
Total 
Spontaneous 
labour 
9 18 32 0 0 0 59 [29.5%) 
Induction of 
labour 
8 7 18 8 11 5 57 [28. 5%] 
Cesarean  
section 
4 13 43 11 12 1 84 [ 42% ] 
 
 The table shows that mothers of small for gestational age babies with 
abnormal umbilical artery Doppler studies needed a cesarean section for fetal 
distress more than the normal Doppler group. In those cases with absent and 
reverse end diastolic flow in umbilical artery, the  labour was induced after 
counseling the parents regarding prognosis  of the baby and in some cases 
labour was induced for maternal indications like severe preeclampsia. 
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Outcome 
 Out of the 200 cases, 169 were live born and 24 were neonatal deaths. 
There were 5 cases of intrauterine deaths of the fetuses and 2 were still born. 
Out of the live borns, 32 had increased perinatal morbidity characterized by 
poor apgar scores, development of necrotizing enterocolitis, hypoxic ischemic 
encephalopathy (HIE), meconium aspiration syndrome (MAS), 
hyperbilirubinemia and prolonged admission in Neonatal Intensive Care Unit 
for reasons like sepsis or birth asphyxia. 
 Outcome data was correlated with Doppler finding in the table given 
below. 
TABLE NO. 8 
 
Number of Patients Grade Perinatal 
Outcome 0 1 2 3 4 5 
Total 
IUD 0 0 0 0 2 
[9%] 
3 
[50%] 
5 [3%] 
Stillborn 0 0 0 0 
2 
[9%] 0 2 [1%] 
NND 0 1  
[3%] 
0 3  
[16%] 
17 
[74%] 
3 
[50%] 
24 
[12%] 
Increased  
Perinatal 
Morbidity 
0 0 15 
[16%] 
15 
[79%] 
2  
[9%] 
 
0 32 
[16%] 
No significant 
adverse 
outcome 
21 
[100%] 
37 
[97%] 
78 
[84%] 
1 
[ 5 %] 0 0 
137  
[68%] 
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Table showing distribution of birth weight in the study group 
TABLE NO. 9 
 
Number of Babies Grade Birth 
Weight 0 1 2 3 4 5 
Total 
Less than 
0 0 0 0 1[20%] 4[80%] 5[2.5%] 
1-1.4 0 0 2[18%] 2[18%] 7[63%] 0 11[5.5%] 
1.5-1.9 7[10.5%] 5[7.5%] 28[42%] 12[18%] 13[19%] 2[19%] 67 [33%] 
2.0-2.4 13[12.6%] 29[29%] 58[54%] 5[4.7%] 2[1.9%] 0 107 
[53.5%] 
2.5 and 
more 
1[10%] 4[40%] 5[50%] 0 0 0 10[5%] 
 
Most of the babies in the group 0, 1, 2 had a birth weight of 2 to 2.4 kgs. 
Most of the babies in group 3 and 4 had birth weights ranging from 1.5 
to 1.9 kgs. 
In group5, 4 babies weighed less than 1 Kg and 2 babies weighed 
between 1.5 to 1.9kgs. 
Perinatal mortality and morbidity was more in cases with low birth 
weights more so if birth weight was less than 1.5 kgs.  
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DISCUSSION 
Fetometry by B-Mode Ultrasound is a reliable method of investigation 
to distinguish between IUGR and normal fetuses. This is probably because in 
IUGR fetuses, the earliest feature is reduced growth that is readily assessed by 
a measurement of abdominal circumference that will show consistently lower 
values than those expected for the particular gestational age. However the B-
Mode ultrasound did not reliably detect the adverse perinatal outcome. 
 Predictive capability of Doppler of adverse outcome in USG confirmed 
IUGR cases, was analyzed. 
TABLE NO.10 
Perinatal Outcome 
 
Adverse Good Total 
Doppler Abnormal 63 116 179 
Doppler Normal 0 21 21 
 
Sensitivity of Doppler in predicting adverse perinatal outcome: 100 % 
Specificity of Doppler in predicting adverse perinatal outcome: 15.3% 
Predictive value of an abnormal Doppler study: 35.19% 
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Predictive value of a normal Doppler study: 100 % 
But on grading the abnormalities from 0 to 5 based on increasing 
severity of altered Doppler indices, we got the following statistics: 
Grade 0 – had a negative predictive value of 100% 
Grade 1 - also had a negative predictive value of 100% and that one          
neonatal death in this grade was due to an unrelated cause 
namely  hand prolapse                                                                                   
Grade 2  –  negative predictive value of 84% 
Grade 3  –  95% positive predictive value for adverse outcome 
Grade 4  – 100% positive predictive value for adverse outcome 
Grade 5 --  100% positive predictive value for adverse outcome               
 100% mortality rate 
We also found that the patients who had mild abnormalities on Doppler 
(Grade 0, 1 and 2), did not have any mortality related to severity of IUGR, nor 
did they have any significant morbidity. 
* There was a significant increase in occurrence of adverse perinatal outcome 
with increasing severity of Doppler abnormalities (P value 0.001). 
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* 97.91% of the patients with marked Doppler abnormalities (Grade 3 or 
more), had adverse perinatal outcome, compared to 10% of those with mild 
Doppler abnormalities (Grade 0, 1 and 2).This again was significant (P 
value 0.001). 
* There was a significant increase in perinatal mortality with increasing 
grades of Doppler (including intrauterine demise, neonatal deaths and 
stillbirths), with a P value of 0.001.All the cases with intra- uterine demise 
and stillbirths as also 23 out of 24 neonatal deaths all had grade 3 or more 
Doppler abnormalities. 
* There was also a significant rise in perinatal morbidity with increasing 
grades of Doppler (P value 0.001). 
These observations show us that Doppler can accurately prognosticate 
IUGR cases and can help in optimizing the time of intervention in a hypoxic 
fetus. Among the 200 USG confirmed IUGR cases, 179 cases revealed Doppler 
abnormalities (89.5%).21 cases revealed normal Doppler findings. No adverse 
perinatal outcome was observed in these cases. It means that if the Doppler is 
normal, in an IUGR case, the possibility of an abnormal perinatal outcome is 
very rare. The normal Doppler result has more importance than an abnormal 
Doppler result.     
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Newham et al evaluated the efficacy of Doppler flow velocity waveform 
analysis as a screening test in pregnancy. They found that prediction of fetal 
hypoxia by Doppler analysis was enhanced in IUGR fetuses, where it was 
weak when umbilical artery PI values were evaluated as primary screening 
tests for fetal hypoxia. These findings very much conform to our observations. 
 The explanation for  these observations is probably that fetal growth 
retardation can be either due to low intrinsic growth potential or due to 
defective placental nutritive and circulatory functions, of which Doppler can 
investigate only the circulatory component. 
GESTATIONAL AGE 
 All the  IUGR cases in our study were 34 weeks or more by gestational 
age. This is explained by 2 reasons: 
1. Patients who were diagnosed to have IUGR at peripheral hospitals were 
referred  late for delivery and NICU (Neonatal Intensive Care Unit)care, by 
which time they had an advanced gestational age, and sometimes marked 
and severe  Doppler abnormalities, which had  a poor fetal outcome. 
2. Patients with preterm IUGR were not included in the study. This was done 
to eliminate the added risk of prematurity on the perinatal outcome of these 
IUGR babies. (i.e.) A baby which may have only a mild growth restriction 
as evidenced by Doppler, if delivered prematurely due to causes unrelated 
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to the growth restriction, may have an adverse perinatal outcome by virtue 
of its extreme prematurity, which can actually lead to false negative results 
for the doppler test. 
3. In a patient who has been booked and monitored regularly, we find that 
each baby has its own growth profile which becomes established only 
around 24-26 weeks. Thus, a deviation from this growth profile resulting in 
growth retardation is effectively detectable only after 28 weeks. This was in 
agreement with the report of Harold Schulman et al in which the most 
reliable time to screen for IUGR is described as after 24-26 weeks. These 
patients are also delivered before the Doppler indices worsen, to ensure that 
the baby has the best chances of survival. 
RISK FACTORS 
In our study, among the cases that had identified risk factors, the 
majority had hypertension as the risk factor (33.5%). This is explained by the 
absence of physiological modification of spiral arteries that causes IUGR in 
hypertensive cases. This observation conformed to the study of Martin et al, 
which reported hypertension as the risk factor of particular importance in 
IUGR. Out of the 200 USG confirmed IUGR cases, 21 cases had normal results 
on Doppler evaluation. All these cases had no increased perinatal 
complications except for a low birth weight. This might be due to the fact that 
these cases were only minimally involved and did not progress beyond the 
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phase of decreased growth in the sequence of events of IUGR. The absence of 
significant redistribution of fetal circulation and hypoxia, as evidenced by 
normal Doppler evaluation would explain the better perinatal performance of 
these fetuses. Our observations were in agreement with the study of Benson et 
al in which all the IUGR fetuses with normal Doppler waveforms were not 
compromised in utero and were healthy although the biometric measurements 
were less than normal. 
Most of the studies (Fleischer et al, Benson et al, Trudinger,  Ardunini   
et al, Arbeille Pet al) have assessed the predictability of IUGR by Doppler 
analysis, and have reported the sensitivity varying from 17% to 78%. But we 
have studied the predictability of adverse perinatal outcome by Doppler 
analysis. Our study result was comparable to the findings of Chambers et al 
(Sensitivity 100% & Specificity 77%). 
    All the 179 cases with abnormal Doppler waveforms were subsequently 
analyzed for their outcome. Only 63 of these cases showed some form of 
increased perinatal complications. The remaining cases showed only low birth 
weight. Out of the 63 cases, 31 were deaths and 32 had neonatal morbidity. 
 From these observations, it is clear that regarding outcome of an IUGR 
case, a negative Doppler evaluation (normal Doppler findings) has a predictive 
value of 100% i.e., all cases with a negative Doppler evaluation will 
subsequently have better outcome without grave perinatal complications. A 
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positive Doppler evaluation as such without any grading of the abnormality on 
the other hand has a predictive value of only 35% i.e., about 35 of 100 cases 
with an abnormal Doppler test will subsequently have a grave outcome. This 
study by Frusca et al reported the predictive value of 37% for an abnormal 
Doppler evaluation in perinatal complications. The predictive value of 35% in 
our study is comparable. 
This shows the necessity for grading of Doppler abnormality to 
prognosticate IUGR cases accurately. 
 
TABLE NO.11 
Grade of Doppler 0 1 2 3 4 5 
No adverse  
perinatal outcome 
21 37 78 1 0 0 
Adverse perinatal 
outcome 
0 1 15 18 23 6 
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P Value-0.001 
In our study, when the perinatal outcome was analyzed according to the 
grades of Doppler abnormality as in the above table, it was obvious that there 
was a significant increase in occurrence of adverse perinatal outcome with 
increasing severity of Doppler abnormalities (P value 0.001). 
           To facilitate comparison, we grouped the patients into 2 groups-Those 
with mild Doppler abnormalities (Grade 0, 1 and 2) and those with marked 
Doppler abnormalities (Grade 3, 4 and 5).Perinatal outcome was compared in 
both groups. 
TABLE NO.12 
 
 
Mild Doppler 
Abnormalities 
Marked Doppler 
Abnormalities 
Total No. of  
patients 
Number of patients 152 48 200 
Number of patients 
with adverse perinatal 
16 [10.5%] 47 [97.91%] 63 [31.5%] 
IUD 0 5 5 
STILL BIRTH 0 2 2 
NND 1 23 24 
Perinatal morbidity 15 17 32 
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From this table, we see that 97.91% of the patients with marked Doppler 
abnormalities (Grade 3 or more) had adverse perinatal outcome, compared to 
10% of those with mild Doppler abnormalities (Grade 0, 1 and 2).This again 
was statistically significant (P value 0.001). 
This is reinforced by the fact that out of 63 patients who had adverse 
perinatal outcome, 47(74.6%) were from the group with marked abnormalities 
on Doppler and 25.39% were from the mild abnormalities group ( i.e.) a  
statistically significant group  of those with adverse perinatal outcome had 
higher grades of Doppler abnormalities.X2-15.88 (P Value-0.001). 
The perinatal mortality rate in our study was 38%which is comparable to 
a study by Trudinger et al who reported perinatal mortality of 20% in cases 
with abnormal Doppler analysis.  
When we analyze the neonatal deaths, 23 out of 24 deaths occurred in 
the group with marked Doppler abnormalities (95.83%). The one death that 
occurred in the group with mild Doppler abnormalities was  due to a cause 
unrelated to the growth restriction-namely hand prolapse with birth asphyxia. 
This dramatic increase in neonatal deaths with increase in Doppler 
abnormalities was found to be statistically significant (X2-110.6 P Value-
0.001).  
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The contributing factors to the neonatal deaths include: 
• Hypoxic Ischemic Encephalopathy  (50% babies) 
• Meconium Aspiration Syndrome   (33.3%) 
• Necrotizing Enterocolitis   (29.16%) 
• Neonatal Sepsis     (16%) 
• Hyperbilirubinemia     (4%) 
More than one cause was responsible in 15 babies. 
All the patients, who had intrauterine demise or stillbirths, had marked 
Doppler abnormalities and this was found to be statistically significant(X2 –
15.55  (P Value-0.001). 
When we analyzed the perinatal morbidity rates, 17 patients out of 32 
(53.12%) had marked Doppler abnormalities and 15 (46.87%) had mild 
Doppler abnormalities. This rise of perinatal morbidity with increasing grades 
of Doppler abnormalities was found to be statistically significant(X2 –26.56 P 
Value –0.001) 
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TABLE NO.13 
Doppler  abnormalities 
Perinatal morbidity 
Mild Moderate 
Total no. of 
patients 
APGAR< 7 AT 5 MINUTES 4 6 10 
HIE 0 3 3 
MAS 5 1 6 
HYPER 1 2 3 
Prolonged NICU admission    
NEC 1 2 3 
 
* 10 babies had low APGAR at 5 minutes 
* 9 babies had prolonged NICU admissions due to reasons like sepsis, 
severe birth asphyxia 
*  6 babies had Meconium Aspiration Syndrome  
*  3 babies had Hypoxic Ischaemic Encephalopathy 
*  3 babies had Necrotizing enterocolitis 
*  3 babies had hyperbilirubinemia 
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 Some babies had more than one of these factors. All these babies had 
some morbidity which could be reliably predicted by the grade of Doppler 
abnormalities (P value 0.001). 
 In our study, when the Doppler abnormalities were analyzed for their 
severity, it was obvious that all cases with a severe grade of abnormality had a 
worse outcome, as compared to the rest of cases with a lesser grade of 
abnormality.  The grades 0 to 5, according to increasing severity were of 
accurate prognostic significance. 
Grade 0 – had a negative predictive value of 100% 
Grade 1 – also had a negative predictive value of 100% and that one 
neonatal death was due to an unrelated cause, namely hand 
prolapse 
Grade 2 – negative predictive value of 84% 
Grade 3 – 95% positive predictive value for adverse outcome 
Grade 4 – 100% positive predictive value for adverse outcome 
Grade 5 - 100% positive predictive value for adverse outcome                 
100% mortality rate 
 This clearly shows the importance of grading- while  grades 0 to 2 have 
a high negative predictive value for adverse outcome, grades 3, 4 & 5 have a 
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high positive predictive value for adverse outcome and grade 5 actually had a 
100%  mortality rate. 
Some of the other observations made in our study were 
* Small for gestational age babies with abnormal umbilical artery wave 
forms were at an increased risk for oligohydramnios than those with 
normal Doppler and they also had a higher incidence of non reassuring 
non stress tests. 
* Small for gestational age babies with abnormal umbilical artery velocity 
wave forms had a shorter diagnosis to delivery interval than those with 
normal Doppler cases. 
* Small for gestational age babies with abnormal Doppler were more 
frequently delivered by cesarean section because of fetal distress. 
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SUMMARY AND CONCLUSIONS 
* Diagnosis of IUGR was done by clinical assessment and serial 
sonography. 
* The routine use of SFH measurement together with the use of serial 
ultrasound examinations in the 3rd trimester of high risk pregnancies 
detected majority of IUGR cases. 
* With the use of Doppler of umbilical and middle cerebral arteries, it is 
possible to predict that an IUGR fetus is not hypoxic. 
* With ductus venosus evaluation,  detection of fetal acidemia  is possible. 
* Predictive value of normal Doppler is 100%. It means that if the Doppler 
is normal in an IUGR fetus the possibility of an abnormal perinatal 
outcome is very rare. So, unnecessary intervention can be reduced in 
those pregnancies with normal Doppler and normal amniotic fluid 
volume. 
* There is a strict co-relation between abnormal umbilical Doppler 
velocimetry and an increased incidence of perinatal complications in an 
IUGR fetus. 
* Days of admission to NICU and incidence of perinatal mortality are 
increased with the worsening of Doppler velocimetry. 
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* In cases with absent and reversed diastolic flow in umbilical artery the 
perinatal morbidity is nearly100%. 
* The perinatal mortality in cases of ductus venosus alteration is 100%. 
* In cases with differential shunting of blood flow to the fetal brain, 
frequent monitoring and early delivery should be done. 
* The Doppler ultrasound finding of increased resistance of umbilical 
artery and decreased resistance of middle cerebral artery, detects the 
fetus at risk of complications 2 weeks earlier than the conventional 
methods like NST. 
* After identifying those fetuses at risk of complications, close monitoring 
is done by non stress test and bio-physical scoring for planning the 
delivery so as to improve the perinatal outcome. 
* Since ductus venosus has been shown to cause irreversible fetal 
compromise and inevitably leads to fetal demise, close monitoring 
should be done so as to deliver before the fetus becomes acidotic which 
is shown by the increase in ductus PI values 
* Thus Doppler can be used as a prognostic tool in IUGR fetus as it gives 
an accurate prediction of the potentially compromised IUGR fetus. 
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ALOKA 3500 
AC 
FL 
GRADE 0 - NORMAL DOPPLER 
 
 
UMBILICAL ARTERY 
MIDDLE CEREBRAL ARTERY 
DUCTUS VENOSUS 
GRADE 1- INCREASED UA PI ALONE
UMBILICAL ARTERY 
MIDDLE CEREBRAL ARTERY 
DUCTUS VENOSUS 
GRADE -2: CEREBRO PLACENTAL RATIO REVERSAL  
UMBILICAL ARTERY 
MIDDLE CEREBRAL ARTERY 
DUCTUS VENOSUS 
GRADE - 3: ABSENT / REVERSED EDF IN UA WITH 
DECREASED MCA PI
UMBILICAL ARTERY 
MIDDLE CEREBRAL ARTERY 
DUCTUS VENOSUS 
GRADE - 4: ABSENT / REVERSED EDF IN UA WITH 
INCREASED MCA PI 
 
 
UMBILICAL ARTERY 
MIDDLE CEREBRAL ARTERY 
DUCTUS VENOSUS  
GRADE - 5: DUCTUS VENOSUS ALTERATION  
 
UMBILICAL ARTERY 
MIDDLE CEREBRAL ARTERY 
DUCTUS VENOSUS  
S.No Name/Age Clinical USG 
PI 
 
Um.A       MCA        DV 
Grade NST Mode of Delivery  
Birth 
weight 
Perinatal 
outcome 
1 Venkatammal 28 Primi 38wks 36 wks AFI 11 0.8 1.8 0.6 0 R Vaginal induced 2.4 kg Good 
2 Meena /30 G2P1L1 39 35 wks 0.7 1.6 0.7 0 R Vaginal induced 1.9 Good 
3 Ansar beevi/24 G3P2L2    24-25 wks 1.9 1.8 1.5 5 NR Vaginal induced 0.8 IUD 
4 Ramani/28 G3P2L2   33-34 wks 1.0 0.8 0.7 2 R LSCS 1.7 Good 
5 Lashmi/20 Primi 38-39 34-35 wks 0.9 1.7 0.6 0 R Vaginal 2.1 Good 
6 Subashini/29 Primi 36-37 34 wks 1.1 0.9 0.7 2 R LSCS 1.6 Good 
7 Narsamma/30 G2A1 36-37 31-32WKS 1.3 1.4 0.8 4 NR LSCS 1.4 NND 
8 Vimla/20 Primi 38- 30-31wks 0.8 1.9 0.6 0 R Vaginal induced 1.8 Good 
9 Parvathi/24 G2P1L0 37- 34-35wks 1.6 1.4 0.7 2 R LSCS 2.5 Good 
10 Anita/21 G2P1L1 40- 34wks 1.8 1.4 0.6 2 R Vaginal induced 2 Good 
11 Rajeswari/26 Primi39- 34-35wks 1.7 1.5 0.7 2 R LSCS 2.5 Good 
12 Vijayalaxmi/35 G2P1L0 36- 32-33wks 1.1 1.9 0.6 0 R LSCS 2.3 Good 
13 Valli/25 G3P2L238w 32-33wks 1.7 1.2 0.7 2 R Vaginal induced 1.6 Good 
14 Regina/24 Primi38- 36-37wks 1.8 1.8 0.8 4 NR LSCS 1.75 NND 
15 Dhanalaxmi/21 Primi 37wks 33-34 wks 1.9 1.4 0.7 3 R LSCS 1.65 NND 
16 Dhana/29 Primi38wks 33wks  AFI4 1.6 1.8 0.7 4 R LSCS 1.5 NND 
17 Kalaivani/24 Primi 38- 34wks 1.7 1.4 0.6 2 R Vaginal induced 2 Good 
18 Vijayaalaxmi Primi 36- 34 wks 1.5 1.9 0.6 1 R Vaginal induced 2.1 Good 
19 Kamatchi/24 Primi 36- 32-33wks 1.7 1.9 0.8 4 R Vaginal induced 1.5 STILLBORN 
20 Sharmila/21 Primi 38- 35-36 wks 1.6 1.3 0.7 2 R Vaginal 2.25 Good 
21 Vasuki/30 G3P2L1 38- 30-31wks 1.7 1.9 0.8 4 NR Vaginal induced 1.65 NND 
22 Geetha/31 G2P1L1 28-30wks 1.8 2.0 1.2 5 NR Vaginal induced 0.9 IUD 
23 Prema/27 Primi40- 36wks 1.7 1.5 0.7 2 R Vaginal 2.75 Good 
24 Shobana/27 G3P1L1A1 33-34wks 1.4 1.3 0.6 2 R Vaginal induced 2.2 Good 
25 Selvi/23 G5P2L0A3 30-32wks 1.5 1.8 0.7 1 R LSCS 1.75 NND 
26 Parvathy/27 Primi 33-34 wks 1.5 1.4 0.6 2 NR LSCS 2.25 Good 
27 Saradha/27 G5P3L2 36- 30wks 1.8 2.0 0.8 4 NR Vaginal induced 1 IUD 
28 Pushpalatha/22 G2P1L0 38- 36 wks 1.7 1.6 0.7 2 R LSCS 2.2 Good 
29 Kirupa/25 G2P1L139- 36-37wks 1.6 1.4 0.6 2 R LSCS 2.2 Good 
30 Sumathi/26 G3P2L0 35- 24 wks 1.9 1.9 1.2 5 R Vaginal induced 1.75 NND 
31 Shanthi/26 G2P1L137- 33-34wks 1.5 1.4 0.6 2 R Vaginal 1.9 Good 
32 Shajitha/24 G3P1L1A1 34-35wks 1.4 1.8 0.6 1 R LSCS 2.3 Good 
33 Shanthi/26 Primi 39- 33-34wks 1.7 1.5 0.7 2 R Vaginal 2.0 Good 
34 Asha/20 Primi36wks 33-34 wks 1.5 1.9 0.6 1 R Vaginal 2.0 Good 
35 Rachel/35 G4P3L035- 26 wks 1.9 1.8 1.3 5 NR Vaginal induced 0.9 IUD 
36 Nithyapriya/27 G3P1L1A13 33wks 1.5 1.9 0.5 1 R LSCS 2.5 Good 
37 Jeyasudha/25 G2P1L137- 30wks 1.7 1.9 0.8 4 NR Vaginal induced 1.9 NND 
38 Anandhi/22 G3A238- 34wks 1.6 1.5 0.7 2 R LSCS 1.75 Good 
39 Malathy/22 Primi39- 36wks 1.5 1.8 0.6 1 R Vaginal induced 2.2 Good 
40 Dowlath/21 Primi36wks 31 wks 1.7 1.5 0.8 3 R LSCS 1.25 NND 
41 Swarnalatha/25 G2P1L139- 34-35wks 1.5 1.2 0.7 2 R Vaginal 2.4 Good 
42 Selvi/26 G2A1 39-40 36-37wks 1.4 1.3 0.6 2 R LSCS 2.25 Good 
43 Balasaraswathi/2 G3P2L137- 37wks 1.5 1.3 0.7 2 R LSCS 2 Good 
44 Malini/25 G3P1L1A13 37wks 1.4 1.9 0.6 1 NR LSCS 2.4 Good 
45 Sathya/20 Primi 36- 28wks 1.8 1.9 0.8 4 NR Vaginal induced 1.1 STILLBORN 
46 Valli/25 Primi36- 32wks 1.5 1.3 0.7 2 R Vaginal 1.8   morbidity 
47 Bhavani/27 Primi36- 32 wks 1.8 1.4 0.7 3 NR LSCS 1.75 morbidity 
48 Arokiyastella/ Primi38- 33 WKS 1.4 1.9 0.6 1 R Vaginal 2 Good 
49 Jaya/24 G3P2L1 36- 28wks 1.5 1.3 0.7 2 R Vaginal 1.5 Good 
50 Latha/26 Primi38- 32-33wks 1.4 1.3 0.7 2 R Vaginal 1.9 Good 
51 Prabavathy/21 Primi39- 34 wks 1.0 1.9 0.6 0 R Vaginal 2.1 Good 
52 Saraswathi/18 Primi 36- 36WKS 1.7 1.5 0.8 2 R Vaginal 1.25 Good 
53 Jagatha/21 Primi38- 36wks 1.6 1.5 0.8 2 R Vaginal induced 2 Good 
54 Nandhini/22 G3A2 36- 34wks 1.4 1.3 0.7 2 R Vaginal 1.75 Good 
55 Meenatchi/20 Primi39- 33-34wks 0.9 1.8 0.6 0 R Vaginal 2 Good 
56 Anitadevi/24 Primi38- 34 wks 1.2 1.9 0.8 1 R Vaginal 1.9 Good 
57 Selvi/20 G1P1L1 37- 32-33wks 1.5 1.4 0.7 2 R Vaginal 1.8 Good 
58 Selvikrishnan/ Primi39- 32 wks 1.6 1.5 0.6 2 R LSCS 2.2 Good 
59 Dhanalaxmi/22 Primi39- 34 wks 1.3 1.9 0.7 1 R LSCS 2.5 Good 
60 Sudha Iyappan Primi37- 32-34wks 1.8 1.9 0.8 4 NR Vaginal Induced 2 NND 
61 Malliga/30 G2P1L1 38- 34wks 1.3 1.9 0.6 1 R Vaginal 2 Good 
62 Shanthi/23 Primi36- 32wks 1.5 1.4 0.7 2 R Vaginal induced 1.75 morbidity 
63 Thilaga/24 Primi39- 36wks 1.6 1.5 0.6 2 R Vaginal 2.2 morbidity 
64 Mala/26 G2P1L138- 36-37wks 1.7 1.6 0.7 2 R LSCS 2.3 morbidity 
65 Sampangi/30 G3P2L136- 32 wks 1.8 1.8 0.7 4 NR Vaginal induced 1.8 NND 
66 Jyothi /20 Primi38-39 36wks 1.4 1.9 0.7 1 R Vaginal 2.25 Good 
67 Punithavathy/ Primi39- 36-37WKS 1.3 1.8 0.8 1 R LSCS 2.3 Good 
68 Nagalaxmi/22 Primi38- 32 wks 1.6 1.5 0.7 2 R Vaginal 1.9 Good 
69 Mariammal/23 Primi37- 36 wks 1.9 2.0 0.9 4 NR LSCS 2.3 morbidity 
70 Umarani /24 Primi 38- 36 WKS 1.4 1.7 0.8 1 R Vaginal 2.25 Good 
71 Malathi/18 Primi39- 36wks 1.5 1.8 0.7 1 R Vaginal 2.2 Good 
72 Ambika/25 Primi38- 37 wks 1.3 1.8 0.8 1 R Vaginal 2.3 Good 
73 Gomathi/27 G3P1L1A1 34 wks 1.8 1.5 0.8 3 R Vaginal induced 2.05 morbidity 
74 Venila/26 G2P1L1 38- 36 wks 1.6 1.4 0.7 2 R LSCS 2.4 Good 
75 Lakshmi/28 G2P1L1 37- 35 wks 1.5 1.4 0.7 2 R Vaginal 2 Good 
76 Shanthi/25 Primi 38- 30 wks 1.7 1.5 0.8 3 R Vaginal induced 2.3 morbidity 
77 Jayanthi/30 G3P1L1A1 36wks 1.3 1.9 0.7 1 R LSCS 2.3 Good 
78 Rajeswari/25 G3P1L1A1 34-35wks 1.5 1.4 0.8 2 R LSCS 2.25 Good 
79 Arifa/28 G2A1 37- 34 wks 1.4 1.3 0.7 2 R LSCS 2.2 Good 
80 Vimala/28 Primi 36- 36wks 1.4 1.2 0.7 2 R Vaginal 2 Good 
81 Tharangini/30 G2P1L1 37- 37wks 1.3 1.8 0.8 1 R Vaginal 2 Good 
82 Eswari/25 Primi38- 36wks 1.4 1.2 0.8 2 R LSCS 2.3 Good 
83 Ponnammal/21 G2P1L139- 37wks 1.5 1.4 0.7 2 R LSCS 2.4 Good 
84 Bhavani/27 Primi 36-37 30wks 1.8 1.5 0.8 3 R LSCS 1.75 morbidity 
85 Laxmi/21 Primi 38- 34wks 1.4 1.3 0.8 2 R Vaginal 2.25 Good 
86 Malar/30 G3P2L1 39- 35-36wks 1.3 1.9 0.7 1 R Vaginal 2.25 Good 
87 Hasanamma/22 Primi 38- 34wks 1.4 1.7 0.6 1 R Vaginal 2 Good 
88 Nalini/31 Primi 37- 32-34wks 1.5 1.3 0.7 2 R Vaginal induced 1.8 Good 
89 Sangeetha/20 Primi38- 36-37wks 1.4 1.7 0.7 1 R Vaginal 2.3 Good 
90 Siromani/26 G2P1L1 38- 35-36wks 1.5 1.4 0.8 2 R LSCS 2.2 Good 
91 Santhanamary G2P1LO 36- 33-34 wks 1.8 1.5 0.9 3 R Vaginal induced 1.5 morbidity 
92 Vasantha/21 Primi 40- 35-36wks 1.3 1.7 0.7 1 R LSCS 2.4 Good 
93 Shaheeda banu G2P1L1 39- 36wks 1.5 1.3 0.6 2 R LSCS 2.3 Good 
94 Menaka/24 Primi 36- 32wks 1.8 1.9 1.3 5 NR Vaginal induced 0.9 NND 
95 Kanchana/26 G5P1L0A3 34 wks 1.7 1.5 .0.8 3 R LSCS 1.8 NND 
96 Sridevi/25 G3A239- 36 wks 1.4 1.2 0.8 2 R Vaginal 2.25 Good 
97 Kamatchi/23 G2P1L1 37- 36 wks 1.3 1.2 0.7 2 R Vaginal 2 Good 
98 Usha 26 Primi 39- 37wks 1.5 1.4 0.7 2 NR Vaginal induced 2.4 Good 
99 Josephine 27 Primi 36wks 32-33 wks 1.9 1.9 1.2 5 NR LSCS 1.5 NND 
100 Deepa 22 Primi 36- 30wks 1.8 2.0 1.3 4 NR Vaginal induced 1.0 IUD 
101 Malliga/26 G2P1L038- 36wks 1.3 1.9 0.7 1 R LSCS 2.1 Good 
102 Prasanthini/30 Primi38- 30wks 1.8 1.8 0.9 4 NR Vaginal induced 0.95 NND 
103 Neelavathi /23 G2P1L037- 36wks 1.4 1.3 0.7 2 R Vaginal 2 Good 
104 Devi/21 Primi38- 35-36wks 1.5 1.3 0.8 2 NR LSCS 2 Good 
105 Saradha/27 Primi37- 36wks 1.8 1.5 0.8 3 R LSCS 1.9 morbidity 
106 Rekha/26 Primi39- 36 wks 1.3 1.9 0.7 1 R Vaginal 2.2 Good 
107 Lakshmi/21 Primi37- 34wks 1.6 1.5 0.7 2 NR Vaginal 1.75 Good 
108 Sivagami/28 Primi36- 36wks 1.4 1.3 0.8 2 R Vaginal 2 Good 
109 Rathi/21 Primi36- 36-37WKS 1.4 1.2 0.7 2 R Vaginal 2.1 Good 
110 Zeenath/23 Primi36- 34wks 1.9 1.8 0.9 4 R LSCS 1.7 NND 
111 Selvi/22 Primi39- 36-37wks 1.4 1.3 0.7 2 NR LSCS 2.1 Good 
112 Thilaga/26 Primi38- 34-35wks 1.5 1.4 0.7 2 NR LSCS 1.9 Good 
113 Chitra/19 Primi39- 36wks 1.4 1.2 0.8 2 NR Vaginal induced 2.4 Good 
114 Thilagavathi/22 Primi38- 36wks 1.3 1.2 0.7 2 R Vaginal 2.2 morbidity 
115 Majeswari /26 G3P2L2 36- 36wks 1.4 1.3 0.6 2 R Vaginal 1.5 Good 
116 Vijayalakshmi Primi 36- 36 wks 1.3 1.2 0.7 2 NR LSCS 1.9 morbidity 
117 Vijayakumari Primi37- 34-35wks 1.7 1.5 0.8 3 NR LSCS 1.75 morbidity 
118 Jayamani/22 G2P1L1 39- 37wks 1.0 1.7 0.7 0 R LSCS 2.5 Good 
119 Sathya/19 Primi 40- 37-38 wks 0.9 1.8 0.6 0 R Vaginal 2.1 Good 
120 Kala/30 G4P2L0A1 37 wks 1.3 1.7 0.8 1 R LSCS 2.5 Good 
121 Maheswari/22 Primi37- 34wks 1.8 1.8 0.9 4 R LSCS 1.7 NND 
122 Rani/24 G3P2L2 38- 36-37 wks 1.4 1.3 0.7 2 NR Vaginal 2 morbidity 
123 Shanthi/29 Primi37- 36wks 1.5 1.3 0.8 2 NR LSCS 1.9 morbidity 
124 Poongodi/30 G2P1L0 36- 32wks 1.4 1.3 0.7 2 R LSCS 1.6 morbidity 
125 Vimala/24 Primi36- 36wks 1.0 1.9 0.7 0 R Vaginal 1.8 Good 
126 Selvi/25 Primi39- 36 wks 0.9 1.8 0.6 0 R Vaginal induced 2.25 Good 
127 Dhanalaxmi/27 Primi36- 34-35wks 1.9 1.8 0.8 4 NR LSCS 1.65 morbidity 
128 Gajalaxmi/26 Primi37- 34wks 1.4 1.3 0.7 2 R LSCS 2.0 Good 
129 Vasantha/33 Primi38- 35wks 1.8 1.5 0.8 3 NR LSCS 2.0 Good 
130 Shanthi/23 Primi 36- 34 WKS 1.9 2.0 0.9 4 R Vaginal induced 1.5 NND 
131 Sharmila/20 Primi39- 36-37wks 1.1 1.8 0.6 0 NR Vaginal 2.25 Good 
132 Dhanalaxmi/28 G3A236- 30-32wks 1.3 1.2 0.6 2 NR Vaginal induced 1.25 morbidity 
133 Laxmi/31 G2P1L138- 36-37wks 1.4 1.3 0.7 2 R LSCS 2.1 Good 
134 Jayalaxmi/23 Primi37- 36-37wks 1.8 1.4 0.9 3 NR Vaginal induced 2 morbidity 
135 Vimala/26 Primi 39- 34wks 1.3 1.8 0.7 1 R Vaginal 1.8 Good 
136 Pachiammal/22 G2P1L1 39- 36wks 1.0 1.8 0.7 0 R Vaginal 2 Good 
137 Shabana /25 G3P1L1A1 33wks 1.8 1.6 0.8 3 R Vaginal induced 1.5 morbidity 
138 Rajalaxmi/21 Primi38- 36wks 1.4 1.3 0.7 2 NR LSCS 2 morbidity 
139 Poornima/28 G2P1L1 38- 36wks 1.3 1.7 0.7 1 R Vaginal 2 Good 
140 Geetha/26 G2P1L1 37- 34wks 1.8 1.4 0.8 3 NR LSCS 1.75 morbidity 
141 Anbarasi/24 Primi 37- 36wks 1.5 1.4 0.8 2 R LSCS 2 Good 
142 Padma/20 Primi 38- 36-37wks 1.3 1.7 0.7 1 R Vaginal induced 2.25 Good 
143 Suguna/26 G3P2L2 38- 36-37wks 1.4 1.8 0.8 1 R Vaginal induced 2.2 Good 
144 Sarojini/21 Primi39-40 37wks 1.5 1.4 0.8 2 R LSCS 2.4 Good 
145 Ponni/25 Primi38- 36 WKS 1.4 1.3 0.7 2 R Vaginal induced 2.3 Good 
146 Sarumathi/30 G2P1L1 37- 36-37wks 1.5 1.3 0.7 2 R LSCS 2.5 Good 
147 Parimala/20 Primi 36- 32-34 wks 1.4 1.3 0.8 2 R Vaginal induced 1.5 Good 
148 Srikumari/27 G2A1 36-37 32 wks 1.8 1.5 0.9 3 NR Vaginal induced 1.55 morbidity 
149 Sheela/25 G2P1L 38- 36 wks 1.4 1.2 0.8 2 R LSCS 2.2 Good 
150 Kirupa rani/33 G3A2 36-37 34 wks 1.8 1.9 0.9 4 NR LSCS 1.8 NND 
151 Prabavathi/19 G3P2L1 36- 34-35 wks 1.5 1.3 0.8 2 R Vaginal induced 1.75 Good 
152 Indrakumari/31 G2P1L1 39- 36-37 wks 1.4 1.8 0.7 1 R LSCS 2.5 Good 
153 Parvathi/20 Primi39-40 37 wks 1.5 1.4 0.8 2 R LSCS 2.2 Good 
154 Devi/26 G5P4L1 38- 36wks 1.4 1.3 0.8 2 R Vaginal induced 2.2 Good 
155 Ramani/31 Primi39- 36 wks 1.5 1.3 0.7 2 R LSCS 2.5 Good 
156 Geethalaxmi/ G3P2L0 37- 34 wks 1.8 1.5 0.9 3 R LSCS 2 morbidity 
157 Kannamma/25 Primi 37- 34 wks 1.4 1.3 0.8 2 NR LSCS 1.7 Good 
158 Gandhi/26 G2P1L1 36- 34wks 1.8 1.4 0.9 3 R Vaginal induced 1.6 morbidity 
159 Subashini/18 Primi 38- 36wks 1.0 1.8 0.7 0 R Vaginal 2 Good 
160 Hemalatha/23 G2P1L1 37- 32-34 wks 1.8 1.9 0.9 4 NR LSCS 1.4 NND 
161 Amsavalli/22 Primi 36- 32-34wks 1.9 1.9 0.8 4 NR LSCS 1.5 NND 
162 Dhanalakshmi/2 Primi 36- 33 wks 1.8 1.9 0.8 4 NR LSCS 1.6 NND 
163 Ambika/22 G2P1L1 38- 36-37wks 1.4 1.2 0.7 2 R LSCS 2.3 Good 
164 Alamelu/26 G3P1L1A1 36wks 1.5 1.4 0.8 2 R LSCS 2.1 Good 
165 Jesintha/22 Primi 37- 34wks 1.3 1.2 0.7 2 NR LSCS 1.9 Good 
166 Meena/26 G2A1 39- 36wkAFI9 1.4 1.3 0.8 2 R LSCS 2.25 Good 
167 Noorie/22 G2P1L139- 36-37wks 1.3 1.8 0.8 1 R LSCS 2.4 Good 
168 Kala/23 G2P1L1 38- 36-37wks 1.4 1.7 0.7 1 R LSCS 2.25 Good 
169 Epsiba/28 G2P1L1 37- 36wks 1.3 1.7 0.8 1 NR LSCS 2.3 Good 
170 Devi/28 Primi39- 34wks 1.5 1.4 0.7 2 R Vaginal induced 2.4 Good 
171 Laxmi/26 Primi37- 32wks 1.4 1.3 0.8 2 R Vaginal 1.75 morbidity 
172 Malarvizhi/25 G3P1L1A13 36wks 1.4 1.8 0.8 1 R Vaginal 2.1 Good 
173 Nagamani/25 Primi 37- 34wks 1.3 1.9 0.7 1 R Vaginal 1.9 Good 
174 Ramadevi/26 Primi36- 30wks 1.9 1.9 0.9 4 NR Vaginal induced 1 NND 
175 Jyothi/30 G3A2 38- 34-35wks 0.9 1.7 0.6 0 R LSCS 1.8 Good 
176 Pushpalatha/28 G2P1L1 39- 32 wks 0.8 1.8 0.7 0 R Vaginal 2.1 Good 
177 Anandalaxmi /24 G3P1L1A1 36wks 1.3 1.2 0.8 2 R Vaginal induced 2.1 Good 
178 Devi/26 Primi39- 36 wks 1.5 1.3 0.7 2 R Vaginal 2 Good 
179 Philomina/23 Primi 39- 35-36wks 1.4 1.3 0.8 2 R Vaginal 2.2 Good 
180 Nagajothi/21 Primi38- 36wks 1.5 1.4 0.7 2 R Vaginal 2.2 Good 
181 Shobana/22 G2A1 37-38 32WKS 1.4 1.2 0.8 2 R LSCS 1.9 Good 
182 Kokila/24 Primi 36- 36WKS 1.4 1.3 0.8 2 R Vaginal induced 1.8 morbidity 
183 Kowsalya/26 Primi 37- 34-35wks 1.5 1.3 0.7 2 R Vaginal induced 2.3 Good 
184 Chinamma/26 G2P1L1 37- 36 wks 1.9 1.8 0.9 4 NR LSCS 1.4 NND 
185 Vijaya/28 G3P2L239- 36 wks 1.4 1.2 0.8 2 R Vaginal 2 Good 
186 Bharathi/18 Primi 37- 34wks 1.5 1.3 0.7 2 R Vaginal induced 1.8 morbidity 
187 Saroja /28 G3A2 39- 32 wks 1.5 1.4 0.8 2 R LSCS 2.5 Good 
188 Dhatchayini/20 Primi39- 36-37wks 1.4 1.3 0.7 2 R LSCS 2.4 Good 
189 Kalavathy/25 G2P1L1 39- 36 wks 1.0 1.8 0.8 0 R LSCS 2.25 Good 
190 Mariammal/38 G5P1L1A3 34 wks 1.6 1.5 0.8 2 NR LSCS 2 Good 
191 Bakiya/30 G2P1L1 39- 35-36wks 1.1 1.5 0.7 0 R Vaginal induced 1.9 Good 
192 Sarawathi/30 Primi39- 36wks 1.0 1.6 0.7 0 R Vaginal induced 2.25 Good 
193 Sumalatha/16 Primi38- 34-35wks 1.0 1.7 0.6 0 R Vaginal induced 1.8 Good 
194 Swarnalatha/24 G2P1L1 38- 34wks 0.9 1.7 0.7 0 R Vaginal induced 1.8 Good 
195 Umamaheswari/ G3P2L1 37- 32-34wks 1.5 1.3 0.9 2 R Vaginal induced 1.75 morbidity 
196 Krishnaveni/20 G2P1L1 39- 36 wks 1.3 1.8 0.8 1 R Vaginal 2.0 Good 
197 Aarthi /25 Primi38- 35wks 1.3 1.8 0.8 1 R Vaginal induced 1.9 Good 
198 Saradha/32 Primi39- 36wks 1.4 1.9 0.7 1 R Vaginal induced 2.2 Good 
199 Seetha/25 Primi36- 32 wks 1.8 1.5 0.8 3 NR Vaginal induced 1.4 morbidity 
200 Thilagavathy/ Primi 36-37 35 wks 1.9 1.5 0.9 3 NR LSCS 1.9 morbidity 
 
PROFORMA 
 
Name : Age : 
Husband's Name : IP No : 
Address : Date of 
Admission: 
    Date of Delivery: 
    Date of Discharge: 
Socio economic Status :   Education: 
Obstetric formula :  LMP  :   EDD : 
Gynec. History : Age at Menarche : 
  Menstrual History : 
  Marital life : 
Obstetric History : 
Past History:                 
H/o Hypertension:  
H/o Diabetes mellitus: 
H/o Bronchial Asthma  
H/o Tuberculosis: 
H/o Heart Disease:  
H/o Renal Disease : 
H/o Epilepsy:   
H/o Connective Tissue disease: 
Abnormalities 
Family History Twinning : 
 PIH : 
Personal History: Smoking : 
 Alcoholism : 
Drug History:   
 
General condition: Build : Nourishment : 
 Height : Weight : 
 Pallor : Clubbing : 
 Jaundice : Pedal Edema : 
 Cyanosis : Lymphadenopathy: 
Vitals: Temperature: Respiratory rate: 
 Pulse Rate  Blood Pressure  : 
Cardiovascular System: 
Respiratory System : 
Thyroid : Breast: 
Per Abdomen  : 
Investigations: 
HB% : PCV : 
Platelets : Urine: Alb : 
B1 Sugar : Sugar : 
B1. Urea : Micro : 
S. Creatinine : C & S : 
S. Uric Acid :  
VDRL : Stool: OVA: 
B1. Group and Type : Cysts : 
Ultra Sound : 
Early Scan : Serial Scan : 
 Presentation    
BPD    
AC    
FL    
HC/AC    
EF.Wt    
CGA    
Placental Position & 
Grade  
  
AFI    
Cong. Anomalies    
 
Provisional Diagnosis          : 
Colour Doppler          : 
Umbilical artery   PI          : 
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ABBREVIATIONS 
 
 
 IUGR  : Intrauterine growth restriction 
 
 SGA  : Small for gestational age 
 
 CTG  : Cardio Tocography 
 
 NST  : Non stress test 
 
 Umb. Ar : Umbilical Artery 
 
 MCA  : Middle cerebral artery 
 
 DV  : Ductus venosus 
 
 USG  : Ultrasonogram 
 
 PI  : Pulsatility index 
 
 RI  : Resistance index 
 
 SFH  : Symphysio - fundal height 
